Home » Topics » Regulatory

Regulatory
RSS

Sunovion receives FDA approval for its once-daily schizophrenia treatment Latuda

Oct. 29, 2010

FDA approves subcutaneous administration of Gamunex-C in primary immunodeficiency

Oct. 22, 2010

Twice-daily tramadol/acetaminophen approved in eight European countries

Oct. 15, 2010

Daiichi Sankyo launches gel formulation of Loxonin in Japan

Oct. 6, 2010

Baxter obtains approval in Austria for Preflucel influenza vaccine

Oct. 1, 2010

FDA approves Allergan's Ozurdex implants for noninfectious uveitis

Sep. 28, 2010

New oral contraceptive Beyaz receives FDA approval

Sep. 28, 2010

FDA approves Savient Pharmaceuticals' pegloticase for gout

Sep. 16, 2010

Daiichi Sankyo's laninamivir is approved for influenza treatment in Japan

Sep. 13, 2010

Positive outcome of decentralized procedure for Faes Farma's bilastine in Europe

Sep. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...